• Something wrong with this record ?

Synthesis of pH-sensitive amphotericin B-poly(ethylene glycol) conjugates and study of their controlled release in vitro

Sedlák M, Pravda M, Staud F, Kubicová L, Týcová K, Ventura K.

. 2007 ; 15 (12) : 4069-4076.

Language English Country Great Britain

New intravenous conjugates of amphotericin B (AMB) with poly(ethylene glycols) (PEG) (M=5000, 10,000, 20,000) have been synthesized and characterised. The intermediate PEGs possess a 1,4-disubstituted benzene ring with aldehyde group at the end of the chain. The benzene ring is connected with PEG at its 4-position (with respect to the aldehyde group) by various functional groups (ether, amide, ester). Reaction of terminal aldehyde group of the substituted PEGs with AMB gave conjugates containing a pH-sensitive imine linkage, which can be presumed to exhibit antimycotic effect at sites with lowered pH value. All types of the conjugates are relatively stable in phosphate buffer at physiological conditions of pH 7.4 (37 degrees C), less than 5 mol% AMB being split off from them within 24 h. For a model medium of afflicted tissue was used a phosphate buffer (pH 5.5, 37 degrees C), in which controlled release of AMB from the conjugates takes place. The imine linkage is split to give free AMB with half-lives of 2-45 min. The rate of acid catalysed hydrolysis depends upon substitution of the benzene ring; however, it does not depend on molecular weights of the PEGs used. The conjugates with ester linkage undergo enzymatic splitting in human blood plasma and/or blood serum at pH 7.4 (37 degrees C) with half-lives of 2-5 h depending on molecular weights of the PEGs used (M = 5000, 10,000, 20,000). At first, the splitting of ester linkage produces the relatively stable pro-drug, that is, 4-carboxybenzylideniminoamphotericin B, which is decomposed to AMB and 4-formylbenzoic acid in a goal-directed manner only at pH 7 (t1/2 = 2 min, pH 5.5, 37 degrees C). A goal-directed release of AMB is only achieved by acid catalysed hydrolysis of imine linkage, either from the polymeric conjugate or from the pro-drug released thereof. The LD50 values determined in vivo (mouse) are 20.7 mg/kg and 40.5 mg/kg for the conjugates with ester linkage (M = 10,000 and 5000, respectively), which means that they are ca. 6-11 times less toxic than free AMB.

000      
00000naa 2200000 a 4500
001      
bmc10001251
003      
CZ-PrNML
005      
20111210155158.0
008      
100120s2007 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sedlák, Miloš, $d 1959- $7 ola2002159209
245    10
$a Synthesis of pH-sensitive amphotericin B-poly(ethylene glycol) conjugates and study of their controlled release in vitro / $c Sedlák M, Pravda M, Staud F, Kubicová L, Týcová K, Ventura K.
314    __
$a Department of Organic Chemistry, University of Pardubice, Cs. legií 565, 532 10 Pardubice, Czech Republic. milos.sedlak@upce.cz
520    9_
$a New intravenous conjugates of amphotericin B (AMB) with poly(ethylene glycols) (PEG) (M=5000, 10,000, 20,000) have been synthesized and characterised. The intermediate PEGs possess a 1,4-disubstituted benzene ring with aldehyde group at the end of the chain. The benzene ring is connected with PEG at its 4-position (with respect to the aldehyde group) by various functional groups (ether, amide, ester). Reaction of terminal aldehyde group of the substituted PEGs with AMB gave conjugates containing a pH-sensitive imine linkage, which can be presumed to exhibit antimycotic effect at sites with lowered pH value. All types of the conjugates are relatively stable in phosphate buffer at physiological conditions of pH 7.4 (37 degrees C), less than 5 mol% AMB being split off from them within 24 h. For a model medium of afflicted tissue was used a phosphate buffer (pH 5.5, 37 degrees C), in which controlled release of AMB from the conjugates takes place. The imine linkage is split to give free AMB with half-lives of 2-45 min. The rate of acid catalysed hydrolysis depends upon substitution of the benzene ring; however, it does not depend on molecular weights of the PEGs used. The conjugates with ester linkage undergo enzymatic splitting in human blood plasma and/or blood serum at pH 7.4 (37 degrees C) with half-lives of 2-5 h depending on molecular weights of the PEGs used (M = 5000, 10,000, 20,000). At first, the splitting of ester linkage produces the relatively stable pro-drug, that is, 4-carboxybenzylideniminoamphotericin B, which is decomposed to AMB and 4-formylbenzoic acid in a goal-directed manner only at pH 7 (t1/2 = 2 min, pH 5.5, 37 degrees C). A goal-directed release of AMB is only achieved by acid catalysed hydrolysis of imine linkage, either from the polymeric conjugate or from the pro-drug released thereof. The LD50 values determined in vivo (mouse) are 20.7 mg/kg and 40.5 mg/kg for the conjugates with ester linkage (M = 10,000 and 5000, respectively), which means that they are ca. 6-11 times less toxic than free AMB.
650    _2
$a financování organizované $7 D005381
650    _2
$a amfotericin B $x chemická syntéza $x chemie $7 D000666
650    _2
$a zvířata $7 D000818
650    _2
$a krev $7 D001769
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a hydrolýza $7 D006868
650    _2
$a myši $7 D051379
650    _2
$a polyethylenglykoly $x chemická syntéza $x chemie $7 D011092
650    _2
$a hmotnostní spektrometrie s elektrosprejovou ionizací $7 D021241
650    _2
$a spektrofotometrie infračervená $7 D013055
650    _2
$a spektrofotometrie ultrafialová $7 D013056
650    _2
$a techniky in vitro $7 D066298
700    1_
$a Pravda, Martin. $7 _AN043408
700    1_
$a Štaud, František, $d 1970- $7 stk2007393932
700    1_
$a Kubicová, Lenka, $d 1964- $7 xx0105104
700    1_
$a Týčová, Kateřina $7 xx0128867
700    1_
$a Ventura, Karel, $d 1952- $7 _AN026096
773    0_
$w MED00000769 $t Bioorganic & medicinal chemistry $g Roč. 15, č. 12 (2007), s. 4069-4076 $x 0968-0896
910    __
$a ABA008 $b x $y 8
990    __
$a 20090310084605 $b ABA008
991    __
$a 20100425172135 $b ABA008
999    __
$a ok $b bmc $g 707176 $s 569972
BAS    __
$a 3
BMC    __
$a 2007 $b 15 $c 12 $d 4069-4076 $i 0968-0896 $m Bioorganic & medicinal chemistry $x MED00000769 $n Bioorg Med Chem
LZP    __
$a 2010-b1/ipme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...